Cardiometabolic and Inflammatory Predictors of Life‐Threatening Ventricular Arrhythmias in Adults Without Structural Heart Diseases
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.126.050176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Hong-Da Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cardiovascular Disease Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Pek…. Hauptthemen laut MEDLINE: Hypertension, Arrhythmias, Cardiac, Inflammation, Tachycardia, Ventricular. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Life‐threatening ventricular arrhythmias (LTVAs) can occur in individuals without apparent structural heart disease, yet the cardiometabolic and inflammatory determinants remain unclear. We aimed to identify clinical, sociodemographic, and lifestyle determinants of LTVAs in structurally normal hearts.
Methods
We included 423 186 UKB (UK Biobank) participants after excluding coronary artery disease, heart failure, cardiomyopathy, and valvular and congenital heart disease at baseline and during follow‐up. The primary end point was incident LTVAs, defined as ventricular tachyarrhythmias, cardiac arrest, sudden cardiac death, and related resuscitation or ablation procedures. Cox models estimated adjusted hazard ratios (HRs) with 95% CIs. Model discrimination was assessed using Harrell's concordance index and explained variance ( R 2 ).
Results
Over a median 13.3 (interquartile range, 12.6–14.0) years, 1116 LTVAs occurred. Cases were older (61 versus 57 years) and more often men (56.1% versus 42.6%). Hypertension (HR, 2.21 [95% CI, 1.90–2.57]), current smoking (HR, 1.78 [95% CI, 1.48–2.13), and male sex (HR, 1.67 [95% CI, 1.45–1.92]) showed the strongest associations with LTVAs. Additional factors associated with increased risk included nonideal sleep, previous smoking, physical inactivity, older age, and higher high‐sensitivity C‐reactive protein. Low‐density lipoprotein cholesterol showed a modest inverse association (HR, 0.89 [95% CI, 0.82–0.97]). Age and hypertension showed the highest discrimination (concordance index, 0.629 and 0.615; R 2 0.0082 and 0.0101), and overall model discrimination was modest. Findings were consistent across sexes and in sensitivity analyses.
Conclusions
In adults without structural heart disease, hypertension, smoking, and male sex show the strongest associations with LTVAs, with additional contributions from age, inflammation, and other lifestyle factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Cardiovascular Disease Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China.
ORCID-Profile: Hong-Da Zhang, Kuo Zhang, Zi-Han Jiang, Xin-Xin Yan, Min Tang
Zitieren
APA
Zhang, H. D., Ding, L., Liu, Y. D., Zhang, K., Qi, Y. J., Jiang, Z. H., Peng, F. H., Yan, X. X., Shen, Y. J., & Tang, M. (2026). Cardiometabolic and Inflammatory Predictors of Life‐Threatening Ventricular Arrhythmias in Adults Without Structural Heart Diseases. Journal of the American Heart Association. https://doi.org/10.1161/jaha.126.050176
Vancouver
Zhang HD, Ding L, Liu YD, Zhang K, Qi YJ, Jiang ZH, et al. Cardiometabolic and Inflammatory Predictors of Life‐Threatening Ventricular Arrhythmias in Adults Without Structural Heart Diseases. Journal of the American Heart Association. 2026. doi:10.1161/jaha.126.050176
BibTeX
@article{Zhang2026,
author = {Zhang, Hong-Da and Ding, Lei and Liu, Yuan-Dong and Zhang, Kuo and Qi, Ying-Jie and Jiang, Zi-Han and Peng, Fu-Hua and Yan, Xin-Xin and Shen, Yu-Jing and Tang, Min},
title = {Cardiometabolic and Inflammatory Predictors of Life‐Threatening Ventricular Arrhythmias in Adults Without Structural Heart Diseases},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.126.050176}
}
EUVIMED